A team of mathematical experts have said that 1729, which is also known as the Ramanujan-Hardy number, is linked to aspects of string theory and...
A team of researchers have indicated that they have started conducting human trials for their new vaccine for AIDS.
The team has already tested the vaccine on non-human primates and the results have been successful. The vaccine succeeded in preventing HIV infection in 50 per cent of the monkeys. The researchers first injected the monkeys with the new AIDS vaccine and then injected with simian immunodeficiency virus or SIV that is similar to HIV.
The injected the monkeys six time overall in order to test the sustainability of the vaccine. The results were very impressive with 50 per cent of those injected with the new vaccine for AIDS were protected even after high exposure to the infection causing virus.
Janssen, a wing of Johnson & Johnson, noted the success of the vaccines and have started human trials of the vaccine. Janssen is the pharmaceutical company behind this new AIDS vaccine. About 400 patients from the United States, East Africa, South Africa and Thailand have enrolled to take part in the study. Health care experts said that if the vaccine is effective, it could have a great healthcare impact.
The study was published recently in the journal Science.
